FDA grants emergency use authorization for tocilizumab in treatment of hospitalized patients with COVID-19
The authorisation is for patients aged >2 years who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation; and is based on data from RECOVERY, EMPACTA, COVACTA and REMDACTA.
Source:
US Food and Drug Administration